Nom du produit:6-Bromo-7-nitro-1,4-dihydroquinoxaline-2,3-dione

IUPAC Name:6-bromo-7-nitro-1,2,3,4-tetrahydroquinoxaline-2,3-dione

CAS:115581-82-3
Formule moléculaire:C8H4BrN3O4
Pureté:98%
Numéro de catalogue:CM555322
Poids moléculaire:286.04

Unité d'emballage Stock disponible Prix($) Quantité
CM555322-100mg in stock ǕƄ
CM555322-250mg in stock ưƞƞ
CM555322-1g in stock ƄưȎ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:115581-82-3
Formule moléculaire:C8H4BrN3O4
Point de fusion:-
Code SMILES:O=C1NC2=C(C=C(Br)C([N+]([O-])=O)=C2)NC1=O
Densité:
Numéro de catalogue:CM555322
Poids moléculaire:286.04
Point d'ébullition:
N° Mdl:
Stockage:Store at room temperature

Category Infos

Quinoxalines
Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

Related Products